Age-indexed cumulative risk of high myopia estimated from axial length and early axial elongation: a 7-year school-based longitudinal cohort study.

IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Frontiers in Medicine Pub Date : 2026-10-05 eCollection Date: 2026-01-01 DOI:10.3389/fmed.2026.1939322
Jing Yang, Hui Li, Bei Du, Desheng Song, Nan Jin, Ruihua Wei
{"title":"Age-indexed cumulative risk of high myopia estimated from axial length and early axial elongation: a 7-year school-based longitudinal cohort study.","authors":"Jing Yang, Hui Li, Bei Du, Desheng Song, Nan Jin, Ruihua Wei","doi":"10.3389/fmed.2026.1939322","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To develop and validate age-indexed models estimating the cumulative risk of high myopia, defined as axial length (AL) ≥ 26.0 mm, using routinely collected ocular biometry, and to evaluate their potential for clinical risk stratification.</p><p><strong>Methods: </strong>This 7-year school-based longitudinal cohort included 7,052 Chinese children aged 6-16 years at baseline who participated in a school-based screening program in Tianjin, China, from 2018 to 2024. Discrete-time survival models with age as the timescale estimated cumulative risk from ages 9 to 18 years. Two models were tested: baseline AL plus sex and baseline AL plus first-year axial elongation (ΔAL) plus sex. Performance was assessed in a participant-level temporal holdout test set using iAUC, iBrier, calibration, and decision-curve analysis, and by school-level internal-external cross-validation using iAUC and iBrier.</p><p><strong>Results: </strong>Overall, 577 participants (8.2%) developed high myopia. In the temporal holdout test set (<i>n</i> = 5,245), the AL + ΔAL model outperformed the AL-only model, with higher discrimination [iAUC, 0.919 [95% CI, 0.902-0.933] vs. 0.851 [95% CI, 0.833-0.869]] and lower prediction error [iBrier, 0.074 [95% CI, 0.068-0.081] vs. 0.087 [95% CI, 0.080-0.095]]. Calibration was close to ideal, decision-curve analysis showed clinical net benefit, and school-level validation confirmed stable performance.</p><p><strong>Conclusions: </strong>Routine AL measurement, particularly when combined with early axial elongation, enables accurate age-specific risk estimation of AL-defined high myopia and provides a transparent basis for timely and proportionate myopia-control decisions.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1939322"},"PeriodicalIF":3.6000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677513/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2026.1939322","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To develop and validate age-indexed models estimating the cumulative risk of high myopia, defined as axial length (AL) ≥ 26.0 mm, using routinely collected ocular biometry, and to evaluate their potential for clinical risk stratification.

Methods: This 7-year school-based longitudinal cohort included 7,052 Chinese children aged 6-16 years at baseline who participated in a school-based screening program in Tianjin, China, from 2018 to 2024. Discrete-time survival models with age as the timescale estimated cumulative risk from ages 9 to 18 years. Two models were tested: baseline AL plus sex and baseline AL plus first-year axial elongation (ΔAL) plus sex. Performance was assessed in a participant-level temporal holdout test set using iAUC, iBrier, calibration, and decision-curve analysis, and by school-level internal-external cross-validation using iAUC and iBrier.

Results: Overall, 577 participants (8.2%) developed high myopia. In the temporal holdout test set (n = 5,245), the AL + ΔAL model outperformed the AL-only model, with higher discrimination [iAUC, 0.919 [95% CI, 0.902-0.933] vs. 0.851 [95% CI, 0.833-0.869]] and lower prediction error [iBrier, 0.074 [95% CI, 0.068-0.081] vs. 0.087 [95% CI, 0.080-0.095]]. Calibration was close to ideal, decision-curve analysis showed clinical net benefit, and school-level validation confirmed stable performance.

Conclusions: Routine AL measurement, particularly when combined with early axial elongation, enables accurate age-specific risk estimation of AL-defined high myopia and provides a transparent basis for timely and proportionate myopia-control decisions.

从眼轴长度和早期眼轴伸长估计高度近视的年龄指数累积风险:一项为期7年的学校纵向队列研究
目的:利用常规采集的眼部生物测量数据,建立并验证以年龄为指标的模型,估计高度近视(定义为眼轴长(AL)≥26.0 mm)的累积风险,并评估其临床风险分层的潜力。方法:这项为期7年的以学校为基础的纵向队列研究包括7,052名6-16岁的中国儿童,他们在2018年至2024年期间参加了中国天津的一项以学校为基础的筛查项目。以年龄为时间尺度的离散时间生存模型估计了从9岁到18岁的累积风险。测试了两种模型:基线AL +性别和基线AL +第一年轴向伸长(ΔAL) +性别。使用iAUC、iBrier、校准和决策曲线分析,通过参与者水平的时间抵抗测试集评估绩效,并使用iAUC和iBrier进行校级内外交叉验证。结果:总体而言,577名参与者(8.2%)发展为高度近视。在时间滞留检验集(n = 5,245)中,AL + ΔAL模型优于AL-only模型,具有更高的判别[iAUC, 0.919 [95% CI, 0.902-0.933] vs. 0.851 [95% CI, 0.833-0.869]]和更低的预测误差[iBrier, 0.074 [95% CI, 0.068-0.081] vs. 0.087 [95% CI, 0.080-0.095]]。校正接近理想,决策曲线分析显示临床净效益,校级验证证实性能稳定。结论:常规AL测量,特别是结合早期轴向伸长,可以准确估计AL定义的高度近视的年龄特异性风险,并为及时和比例的近视控制决策提供透明的依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书